Efficacy of methyldopa versus nifedipine in mild and severe pregnancy induced hypertension
Abstract
Background: Hypertension and its associated disorders are major health concerns during pregnancy. Antihypertensive therapy prescribes, when blood pressure is >140/90 mm of Hg, to minimize elevated blood pressure. The present study aimed to assess the efficacy of nifedipine and methyldopa in the antihypertensive treatment of mild and severe pregnancy induced hypertension (PIH).
Methods: A total one hundred Patients attending antenatal clinic of the department between 26-37 weeks of gestation suffering from PIH were recruited. Participants were divided in to two groups i.e. group-I consists of 50 patients medicated with oral methyldopa and group-II consists of 50 patients treated with Nifedipine 10mg.
Results: Methyldopa reduced systolic blood pressure (SBP) from 162±19.6 to 140.3±10.01 and diastolic blood pressure (DBP) from 99.6±8.8 to 96.17±6.4. Nifedipine reduced SBP from 99.6±8.8 to 96.17±6.4 and DBP from 99.2± 7.4 to 93.45±12.3. Response to methyldopa and nifedipine was almost similar in mild PIH but in severe PIH, 65.5% of patients required additional drug atenolol for adequate control of PIH.
Conclusions: Methyldopa and nifedipine are effective drugs for lowering blood pressure when given orally, Methyldopa was found to have a higher incidence of Intra uterine growth restriction while nifedipine was found to have an increased incidence of perinatal mortality.
Keywords
Full Text:
PDFReferences
Kaunitz AM, Hughes JM, Grimes DA, Smith JC, Rochat RW, Kafrissen ME. Causes of maternal mortality in the United States. Obstet Gynecol. 1985 May 1;65(5):605-12.
Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:892-8.
Gifford RW, August PA, Cunningham G. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:1-22.
Krauss T, Kuhn W, Lakoma C. Circulating endothelial adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol. 1997;177: 439-443.
Giannubilo SR, Bezzeccheri V, Cecchi S, Landi B, Battistoni GI. Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy. Arch Gynecol Obstet. 2012;286:637-42.
Margaard S, Forman A, Anderson KE. Effect of Nifedipine on human placental artries. Gynaecol Obstet Investig. 1984;18:217-24.
Abalos E, Duley L, Steyn DW, Henderson-smart DJ. Antihypertensive drug therapy to mild to moderate hypertension during pregnancy. Cochrane Library. 2003;1.
Cvijic M, Horvat M, Jernejcic P, Verdenik I, Geršak K. Analysis of the intake of drugs used in hypertensive disorders during pregnancy. Zdrav Vestn. 2010;79:412-8.
Zibaeenazhad MJ, M Ghodsi P Arab, Gholzom N. the prevalence of hypertensive disorders of pregnancy in Shiraz, Southern Iran. Iranian Cardiovascular Res J. 2010;4:169-72.
Redman CWG, Gallery ED, Mitchell MD. Fall in BP in response to volume expansion in pregnancy associated hypertension (PE): Why does it occur? BMJ. 1984;2(2):177-82.
Lardoux H, Blazquez G, Leperlier E, Gérard J. Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol. Arch Mal Coeur Vaiss. 1988;81:137-40.
Sibai BM, Barton JR, Sherif AKL, Sarinoglu C, Mercer BM. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol. 1992;167:879-84.
Bharathi KN, Prasad KVSRG, Jagannath P, Nalini KS. Comparison of Nifedipine with Methyldopa for Control of Blood Pressure in Mild to Moderate Pregnancy Induced Hypertension. J Clin Diagnos Res. 2010;4(3):2406-9.
Jayasutha J, Ismail AM, Senthamarai R. Evaluation on efficacy of Methyldopa monotherapy and combination therapy with Nifedipine in pregnancy-induced hypertension. Der Pharmacia Lettre. 2011;3:383-7.
Vidyadhar B, Giri P, Gavhane SP. A study to compare the efficacy of low dose magnesium sulphate (Dhaka) regime with Pritchard regime in eclampsia. Int J Biomed Adv Res. 2012;03(01):53-58.
Redman CWG, Berlin IJ, Bonnar J, Ounsted MK. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976 Oct 9;2(7989):753-6.
Seshadri L, Venkataraman I. Hypertension in Pregnancy Outcomes, Proteinuric vs. Nonproteinuric. J Reprod Med. 1997;42(2):88-90.
Ismail AAA, Medhat I, Tawfic TAS, Kholeif A. Int J Gynecol Obstet. 1993;1:39-43.